Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B
Clinical trial NCT02726789 · COMPLETED
Trial details
- NCT number
- NCT02726789
- Sponsor
- Replicor Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.